biological terrorism edward l. goodman, md, chief of infectious diseases presbyterian hospital of...
TRANSCRIPT
BIOLOGICAL TERRORISM
Edward L. Goodman, MD, Chief of Infectious Diseases
Presbyterian Hospital of Dallas
December 14, 2005
Biological Terrorism
Use of biological agents to intentionally produce disease or intoxication in susceptible populations to meet terrorist aims
Has been done in the past on a limited scale
U.S. must be prepared to respond to this threat
History of Biological Warfare
In 1346, Tartar army hurled corpses of plague victims over the walls of Caffa, a seaport on the Crimean coast
In 1718, Russians used same tactic against Sweden
During the Pontiac Rebellion in 1763, the British army provided the Delaware Indians with blankets and handkerchiefs from the “Smallpox Hospital”
History of Biological Warfare (cont.)
German program in WWI Japanese program in WWII In 1943, the U.S. began research into the
offensive use of biological agents: Program stopped by President Nixon in 1969
History of Biological Warfare (cont.)
In 1972, U.S. and many other countries signed the Biological Weapons Convention
Former Soviet Union program began massive effort in 1970s
Today, term “warfare” is outdated…terrorism of civilian populations major risk: Anthrax in 12 persons 2001
Why There was a Belief Bioterrorism in the U.S. Would Not Happen
Biologic weapons seldom used Their use is morally repugnant to most Technologically difficult? Concept of “nuclear winter” was
“unthinkable” and thus dismissed until suicide hijackers and anthrax appeared
The “Coming of Age” and Bioterrorism
Perpetrators Availability of biological agents Methods of dissemination
The Spectrum of Terrorists
State-sponsored Insurgent/rebel Doomsday/cult-type group Non-aligned terrorists Splinter groups Lone offenders
Sources of Agents for Terrorism Use
World Directory of Collections of Cultures and Microorganisms 453 worldwide repositories in 67 nations 54 ship/sell anthrax 18 ship/sell plague
International black-market sales associated with governmental programs
Methods of Dissemination of Biologic Agents
Postal service: never previously reported Aerosol
Enclosed areas Community-wide
Ingestion Mass produced food Water supplies
Syndromes Suggesting BT
Encephalitis Hemorrhagic mediastinitis Pneumonia with abnormal liver function Papulopustular rash Hemorrhagic fever Descending paralysis Nausea, vomiting +/- diarrhea
Biological Terrorism: Likely Agents
Bacterial: Anthrax Q fever Brucellosis Tularemia Plague
Viral: SmallpoxViral encephalitidesViral hemorrhagic fever
Toxin: BotulismRicin Staph, Enterotoxin B
Ideal Characteristics for Potential Biological Terrorism Agent
Inexpensive and easy to produce Can be aerosolized (1-10µm) Survives sunlight, drying, heat Cause lethal or disabling disease Person-to-person transmission No effective treatment or prophylaxis
Anthrax
Caused by Bacillus anthracis, a rod shaped, sporulating organism
Is a zoonotic disease in cattle, sheep, and horses
Transmission through scratches or abrasions of skin, wounds, eating insufficiently cooked infected meat, or inhalation of spores
Anthrax (cont.)
Case fatality in untreated inhalational disease is almost 100% In recent 2001 occurrence, “only” 3/6 died
Incubation 1 – 45 days, most within 21 days Initial flu-like symptoms are often followed by
abrupt development of severe respiratory distress, shock, and death within 24 hours
Bush, L. M. et al. N Engl J Med 2001;345:1607-1610
Anteroposterior Chest Radiograph Obtained on Admission, Showing the Widened Mediastinum That Is Characteristic of Anthrax
Bush, L. M. et al. N Engl J Med 2001;345:1607-1610
Cerebrospinal Fluid Specimen Containing Many Polymorphonuclear White Cells and Gram-Positive Bacilli (Gram's Stain, x1000)
Dixon, T. C. et al. N Engl J Med 1999;341:815-826
Differential Diagnosis of Clinical Manifestations of Anthrax
Anthrax (cont.)
Medical management must be reserved for those with early symptoms or no symptoms
Use of antibiotics for treatment (penicillin, ciprofloxacin, or IV doxycycline) and prophylaxis and vaccination
No secondary transmission
Swartz, M. N. N Engl J Med 2001;345:1621-1626
Recommendations for Antimicrobial Therapy of Clinical Inhalational Anthrax
Anthrax (cont.)
Weaponized by the U.S. in 1950s and 60s Major emphasis of USSR program Can be delivered as aerosol
Incubation-Days
0-67-1314-2021-2728-44
Cases*
62896
11
Died
625765
Days to Death
4.52.53.04.53.5
* 15 additional cases without an exact date of onset; all died.
Inhalational AnthraxSverdlovsk, USSR, 1979
Shopping Mall Scenario - Denver
Anthrax aerosolized into shopping mall ventilation system; 10,000 people are present and 9,000 people are exposed; terrorist announces attack at 24 hours.
90% of exposed started on antibiotics by end of day 2, 10% cannot be found initially
Total number hospitalized: 4,950; total requiring ICU care: 2,925; total deaths: 855; total ventilators required: 2601
Shopping Mall Scenario – Denver (cont.)
The 13,000 military beds deployed for the Persian Gulf War would STILL not provide enough ICU beds (approximately 1,300)
Even a small biological terrorism event completely overwhelms a city’s medical care resources
Smallpox
Killed more than 500 million persons in the 20th century despite being eradicated in 1978
Mortality of 30% in susceptible population Incubation period of 8 to 16 days
Smallpox (cont.)
Clinical manifestations begin acutely with fever, rigors, vomiting, headache and backache
Approximately 10% of light-skinned patients exhibit erythematous rash during early phase
Two to three days later, an enanthem appears on face, hands, and forearms
Smallpox (cont.)
Transmission begins with rash and lasts throughout convalescence
Ongoing transmission is critical factor Most in the world are no longer protected
by vaccination Currently vaccine and treatment limited
January February
4
3
2
1
Case
s
13 15 17 19 21 23 25 27 29 31 2 4 6 8 10 12 14 16 18
Hospital Stay Case 1
Date of Onset of Smallpox Cases by Two-Day IntervalsMeschede Hospital, 1970
Challenges in Recognizinga Bioterrorism Attack
Biologic agents with delayed onset Medical community is unfamiliar with
many of these diseases Current surveillance system may not be
adequate to detect attack
Epidemiological Clues to BT Event
Uncommon illness in epidemic form Explosive point source epidemic curve Unexplained high mortality Discordant attack rate: outdoor>indoor Sentinel illness – even one case of
anthrax or smallpox
Syndromes Suggesting BT
Encephalitis Hemorrhagic mediastinitis Pneumonia with abnormal liver function Papulopustular rash Hemorrhagic fever Descending paralysis Nausea, vomiting +/- diarrhea
Ten CommandmentsSummary
1. Index of Suspicion2. Protect Thyself and Thy
Patients3. Assess the Patient 4. Decontaminate 5. Diagnosis6. Treatment7. Infection Control8. Alert 9. Epidemiologic Assessment10. Spread the Gospel
Response Planning
Federal government State and local government Healthcare systems Media Infrastructure support
Impact on Healthcare System
Potential for widespread illness, in unprecedented numbers
Limited therapeutic stockpiles Need special protective measures for
medical care, clinical lab, and autopsy Panic/terror among the ill, the exposed,
and healthcare providers
Other Critical Issues
Legal aspects Criminal investigation Controlling civil disorder Quarantine
Continued public health activities
Planning Responses to Biological Terrorism
Are we ready? Should we get ready? Is it possible to be effectively prepared?